• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      Ape-directory
      AVCJ Private Equity Online Directory

      With its wide network of senior industry contacts, the directory is the most comprehensive online directory on private equity and venture capital in Asia. It is easy to navigate, enabling access to Asian private equity firms and professionals.

      Read more
      2016-china-cover
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

covid-19

beach-closed
Australia PE: Brave new world

As Australia contemplates opening its tightly controlled borders and finding a way to live with COVID-19, private equity probes an opportunity set in transition yet surprisingly stable

  • Australasia
  • 28 September 2021
coronavirus-covid-mask-healthcare
CDC joins $75m round for India medical B2B marketplace

CDC Group has contributed $27.5 million to a $75 million Series C round for Medikabazaar, an Indian medical B2B marketplace and COVID-19 supply chain operator.

  • South Asia
  • 27 September 2021
computer-analytics-report-research-business
Virtual reporting: Lost in translation

GP-LP reporting in the age of remote portfolio assessments and stilted video catchups leaves much to be desired. Both sides are trying to bridge the divide, but no best-practice approach has emerged

  • GPs
  • 14 September 2021
vaccines-healthcare-drug-pharma
China vaccine developer Abogen raises $700m

Suzhou Abogen Biosciences, a Chinese vaccine developer targeting COVID-19, has raised $700 million in Series C funding featuring Temasek Holdings, Loyal Valley Capital, and Lilly Asia Ventures.

  • Greater China
  • 20 August 2021
avcj-20210721cvr-72
Weekly digest - July 21 2021

  • Region
  • 21 July 2021
online-insurance
Deal focus: Targeting an insurance pain point

India’s Digit Insurance has achieved a valuation of $3.5 billion in four years with a thesis that simple is better – and more trustworthy. COVID-19 added more rocket fuel

  • South Asia
  • 21 July 2021
everything-nothing-sign-fundraising
Asia fundraising: Fortune favors the bold?

LPs cannot survive indefinitely on re-ups and new commitments to managers they know well. Questions are being asked internally as to what it would take to back an Asian GP sight unseen

  • GPs
  • 14 July 2021
avcj-20210707cvr-72
Weekly digest - July 07 2021

  • Region
  • 07 July 2021
insurance-insurtech
Faering leads $200m round for India's Digit Insurance

Indian private equity firm Faering Capital has led a $200 million round for local insurance company Digit Insurance at a valuation of $3.5 billion.

  • South Asia
  • 05 July 2021
casino-gambling
PE & gambling: Ante up

Private equity has exhibited consistent appetite for gambling-related assets amid pandemic-fueled uncertainty. Regulation remains a significant wildcard in Asia. Reputational risk, not so much

  • Australasia
  • 30 June 2021
nasal-spray2
Deal focus: Australia’s ENA hits COVID-19 in the nose

Australian investors see hope in ENA Respiratory, a nasal spray specialist aiming to complement global COVID-19 vaccine programs with an immune system-boosting product

  • Australasia
  • 22 June 2021
nasal-spray
Australia COVID-19 nasal spray maker raises $25m

ENA Respiratory, an Australian biotech company developing a nasal spray for the prevention of COVID-19, has raised A$32 million ($25 million) with support from local venture capital investor Brandon Capital.

  • Australasia
  • 17 June 2021
coronavirus-covid-vaccine-healthcare
China mRNA specialist Stemirna gets $200m in funding

Stemirna Therapeutics, which claims to be the first biotech company to bring an mRNA therapeutics and nanomedicine platform to China, has raised $200 million in funding.

  • Greater China
  • 04 June 2021
myanmar-flag2
Myanmar: Asia’s anguish

Myanmar has proven unique among Asia’s frontier markets in terms of volatility and risk. As its ongoing humanitarian and political catastrophe deepens, a sense of helplessness has taken root

  • Southeast Asia
  • 01 June 2021
avcj-20210512cvr-72
Weekly digest - May 12 2021

  • Region
  • 12 May 2021
avcj-20210505cvr-72
Weekly digest - May 05 2021

  • Region
  • 05 May 2021
coronavirus-covid-vaccine-healthcare-2
Chinese COVID-19 vaccine developer Clover files for IPO

Clover Biopharmaceuticals, a Chinese pre-revenue drug developer that has raised $315 million across several funding rounds since 2011, has filed for a Hong Kong IPO.

  • Greater China
  • 27 April 2021
lab-drug-healthcare-medicine
Invesco leads $155m round for China's Brii Biosciences

Invesco has led a $155 million Series C round for China-focused infectious diseases drug developer Brii Biosciences.

  • Greater China
  • 25 March 2021
coronavirus-covid-mask-man-city
Asian GPs prioritize portfolio resilience - Bain & Co

Three out of five GPs in Asia Pacific would be willing to forego at least 5% of near-term profit if that sum could be invested in making their portfolio companies more resilient across a range of metrics.

  • GPs
  • 25 March 2021
nepal
CDC, FMO, SDC launch Nepal investment platform

European development finance institutions CDC Group and FMO and the Swiss Agency for Development and Cooperation (SDC) have jointly launched a market building platform in Nepal.

  • South Asia
  • 24 March 2021
online-insurance
Jungle joins $46m Series D for India's Turtlemint

Indian online insurance broker Turtlemint has closed its Series D round at $46 million following a significant contribution from early-stage investor Jungle Ventures.

  • South Asia
  • 10 March 2021
video-interview
Fundraising talent: New calls of duty

The trend toward more stringent due diligence in recent years has maximized fundraising complexity at a time when the professionals involved must adapt to unfamiliar virtual forums

  • Fundraising
  • 24 February 2021
klook
Aspex leads $200m Series E for Hong Kong's Klook

Aspex Management has led a $200 million Series E round for Klook as the Hong Kong travel app pivots to domestic holiday services during a freeze in international tourism.

  • Greater China
  • 27 January 2021
hkvcajan2021
COVID-19 changing conduct as much as tech usage

Experiences vary across geographies as Asian GPs adapt to pandemic working conditions. Technology use is up, but the most lasting changes may be more cultural in nature.

  • GPs
  • 21 January 2021
1 2 3

Most read

stock-shares-ipo
HKEX relaxes rules for IPOs by pre-profit tech companies
asia-map-globe
Asia GPs must get smarter on target selection, costs - Bain & Co
healthcare-medical-app
Longreach buys Japan healthcare SaaS player
pr-electronics
Asia-Europe investor AGIC supports Danish electronics buyout
campus-activewear
TPG completes exit from India's Campus Activewear
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013